These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 3136630

  • 1. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 3. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG, Ikram H, Kenealy M, Levy L.
    Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 01; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 5. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL, Jolivette DM, Fredell PA.
    Am J Cardiol; 1988 Aug 25; 62(6):62D-66D. PubMed ID: 3136638
    [Abstract] [Full Text] [Related]

  • 6. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 7. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH, Zabel M.
    Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [Abstract] [Full Text] [Related]

  • 8. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF, Neuzner J.
    Z Kardiol; 1996 Aug 20; 85 Suppl 6():45-60. PubMed ID: 9064982
    [Abstract] [Full Text] [Related]

  • 9. A shared pathway in atrioventricular nodal reentrant tachycardia and atrial flutter: implications for pathophysiology and therapy.
    Interian A, Cox MM, Jimenez RA, Duran A, Levin E, Garcia O, Cooper DK, Castellanos A, Myerburg RJ.
    Am J Cardiol; 1993 Feb 01; 71(4):297-303. PubMed ID: 8427171
    [Abstract] [Full Text] [Related]

  • 10. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 11. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 12. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI.
    Am Heart J; 1989 Feb 25; 117(2):365-9. PubMed ID: 2492738
    [Abstract] [Full Text] [Related]

  • 13. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 25; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L, Alvarez A, Cianciulli T, Quiroga J, Califano J, Mautner B.
    Arch Inst Cardiol Mex; 1989 Dec 25; 59(3):241-4. PubMed ID: 2506843
    [Abstract] [Full Text] [Related]

  • 15. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW, Camm AJ, Bexton RS, Hellestrand KJ.
    Clin Cardiol; 1987 May 25; 10(5):317-22. PubMed ID: 3109795
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 18. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ.
    Eur Heart J; 1995 Dec 15; 16(12):1930-5. PubMed ID: 8682029
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 20. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS, Kim SS, Ruffy R.
    Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.